Welcome!
CGS-CIMB Research
Broker's Calls
CGS-CIMB downgrades SPH REIT to 'hold' as recovery already 'priced in'; other analysts maintain 'hold' call
CGS-CIMB and DBS have kept their TPs on the REIT at 95 cents and 96.4 cents respectively.
April 04, 2022
Broker's Calls
Analysts remain positive on Keppel Corp amid merger delay and divestment of logistics business
CGS-CIMB has kept its TP at $7.20, while Citi Research has pegged a TP of $6.35.
April 01, 2022
Broker's Calls
CGS-CIMB starts Pan-United at 'add'; SAC Capital sees 'brightening outlook' with higher TP of 53 cents
As at 3.23pm, shares in Pan-United are trading 3 cents higher or 7.79% up at 41.5 cents.
March 30, 2022
Broker's Calls
RHB downgrades CICT to 'neutral' while other analysts keep 'buy' call following reopening and acquisition
In its report, RHB also expects CICT's next potential acquisition to be its remaining stake in CapitaSpring.
March 28, 2022
Broker's Calls
‘Buy’ MCT and ‘hold’ on to MNACT with introduction of all-cash option: analysts
Analysts positive on MCT and MNACT following the introduction of an all-cash option offered to MNACT unitholders
March 23, 2022
Broker's Calls
Strong income visibility following UK agreements 'key positive' for Elite Commercial REIT
Analysts are keeping their target prices unchanged at 76 British pence and 80 British pence for CGS-CIMB and DBS respectively.
March 09, 2022
Broker's Calls
Turnaround in sight for SembMarine: analysts
CGS-CIMB and DBS have kept "hold" on SembMarine, while UOB Kay Hian remains the most optimistic at "buy".
March 08, 2022
Broker's Calls
'Buy' ESR-REIT as it inches closer to merger with ARA Logos Logistics Trust: analysts
The EGM for the ESR-REIT and ARA Logos Logistics Trust merger has been set for March 21.
March 08, 2022
Results
'Buy' calls around for ComfortDelGro as it drives towards a bright outlook
Analysts are driving towards a 'buy' for ComforDelGro as it has a smooth journey ahead.
March 03, 2022
Broker's Calls
PhillipCapital upgrades Venture Corp to 'accumulate'; other analysts keep 'buy' on the stock on robust FY2022 outlook
The analysts' target prices range from $20 to $23.32.
March 02, 2022